A new synthetic approach to C-2 triazole-linked bioconjugates of lupane triterpenoids with 3'-azido-3'-deoxythymidine (AZT) based on Cu I -catalyzed 1,3-cycloaddition between alkynes and azides is described. The proposed strategy towards AZT-betulinic acid hybrid molecules as potential anti-HIV agents makes it possible to vary the C-3 and C-28 pharmacophores in triterpene moieties. The C-2 propargyl-substituted betulinic acid and its mono-or bi-functional derivatives with side chain at C-3 and/or C-28 positions were successfully synthesized by employing the click reaction.
Introduction
The pentacyclic group of lupane triterpenoids (betulin and betulinic acid) represents one of the very important classes of plant natural products that are derived biosynthetically from squalene cyclization. These secondary metabolites possess a wide range of biological effects including antitumor, anti-inflammatory, antibacterial, antimalarial, and antiviral (anti-HIV) activities. [1] [2] [3] [4] The broad spectrum of useful biological properties of lupane triterpenoids is successfully combined with their acceptable systemic toxicity towards animals. Owing to the presence of easily transformable functional groups (3-OH, 28-OH, 28-COOH, C-19 isoprenyl) in the triterpene skeleton, betulin and betulinic acid have a high synthetic potential and are actively used in transformations with the aim to design new drugs. Currently, numerous semisynthetic betulin and betulinic acid derivatives have been prepared; particular attention deserve new potential anti-HIV agents, which show antiviral activity when present in nanomolar concentrations. [5] [6] [7] [8] [9] [10] [11] ( Figure 1 ) Figure 1 . Chemical structures of betulinic acid and derivatives with potent HIV-1 antiviral activity.
The structure-activity relationship studies of anti-HIV-1 lupane triterpenes demonstrated that, in terms of the mechanism of antiviral action, betulinic acid derivatives are subdivided into two types, depending on the structures of С-3 and С-28 pharmacophores. The С-3 acyl derivatives of betulinic or dihydrobetulinic acid are antiretroviral compounds of a new class inhibiting virus protease, which plays a key role in HIV maturation at a late stage of virus replication. 5, 6, 8 For example, 3-O-(3',3'-dimethylsuccinyl)betulinic acid (DSB, PA-457, MPC-4326, or Bevirimat), which is the most promising in this group of anti-HIV agents, prevents cleavage of the capsid protein p25 (CA-sp1) to mature capsid p24 (CA), which results in morphologically defective, noninfectious viral particles. 8 Unlike Bevirimat and its 3-О-acyl analogues, С-28 amide betulinic acid derivatives act at the initial stage of HIV-1 entry into a human cell, thus preventing the virus fusion with the cell plasmatic membrane. [12] [13] [14] The design of two parallel side chains at the С-3 and С-28 lupane skeleton atoms has resulted with 4N NaOH in a MeOH-THF mixture furnished triterpenoids 8b, 9b, and 12b-15b. Some of these compounds (12b, 14b and 15b) were involved in the CuACC reactions with AZT to afford the corresponding hybrid molecules 23-25 (Schemes 2 and 3). Triterpenoids 8b, 9b, 12b and 13b were converted into С-3 dimethylsuccinyl derivatives 16-19 in 42%-90% yields under the reaction conditions used for acylation of compound 4 into ester 6. The reaction of С-2 propargyl betulinic acid derivatives 4 and 5 with AZT induced by CuI in Bu t OH at 70 o C gave target compounds 20 and 21 in 70% and 55% yields, after column chromatography on SiO 2 (Scheme 3).
However, under these conditions, acetylenic derivatives 6 and 16-19 react with AZT over long periods of time, with the yields of final products being not higher than 32%. The reaction conditions and the yields of conjugates were substantially affected by replacement of the Bu t OH solvent by DMSO. With the use of CuSO 4 . 5H 2 O and sodium ascorbate in DMSO, substrates 6, 12b, 14b, 15b, and 16-19 react with AZT at room aminopropylpiperazine, Boc-diaminoethane and Boc-diaminooctane and methyl 5-piperazine pentanoate were prepared according to known procedures. 12, 29 General procedure for the preparation of conjugates 8а-11а, 14а and 15а. Oxalyl chloride (0.3 mL, 3 mmol) was added with stirring to a solution of triterpenoid 5 (1 mmol) in dry CH 2 Cl 2 (5 mL) precooled to 0°С, and stirring of the reaction mixture was continued at room temperature for 2 h. Then the solvent and excess oxalyl chloride were removed under vacuum. The residue was treated with ethylenediamine (0.4 mL, 6 mmol), 1,8-diaminooctane (0.87 g, 6 mmol), N-Boc-bisaminopropylpiperazine (0.48 g, 1.6 mmol), N-Boc-ethylenediamine (0.26 g, 1.6 mmol), N-Boc-1,8-octanediamine (0.39 g, 1.6 mmol), or methyl 5-piperazinepentanoate (0.32 g, 1.6 mmol) and with triethylamine (0.2 mL, 1.6 mmol) in dry CH 2 Cl 2 (15 mL), and the mixture was stirred at room temperature for 16-20 h until no starting material was observed by TLC. The solution was then diluted with CH 2 Cl 2 (20 mL) and washed three times with brine and distilled water. The organic layer was dried over anhydrous MgSO 4 and concentrated under reduced pressure. General procedure for the preparation of compounds 8b, 9b, 12b-15b. To a solution of the appropriate ester intermediate 8а, 9а, 12а-15а (1 mmol) in MeOH (8 mL) and THF (4 mL) was added 4 N NaOH (4 mL). The reaction mixture was stirred at room temperature for 15-20 h (monitoring by TLC) and then neutralized with 20% HCl. The solution was dried under vacuum and reconstituted with CH 2 Cl 2 . The organic layer was washed with brine and dried over anhydrous MgSO 4 and concentrated under reduced pressure to obtain pure compounds 8b, 9b, 12b-15b. 50.1 (C-18), 46.8 (C-19), 44.8 (C-1), 42.5 (C-14), 40.8 (C-8), 39.6 (CH 2 in octylamine), 39.1 (C-4, CH 2 in octylamine), 38.5 (C-13), 37.7 (C-22), 37.3 (C-10), 34.8 (C-7), 34.4 (C-2), 33. (18 1-(3'-Deoxythymidine)-1H-1,2,3-triazol-4-yl]-N-[N'-(tert-butoxycarbonyl)-{3-[4-(3-aminopropyl) piperazinyl]propyl}}-2α-methyl betulinic acid amide (24 C-17) , 57.0 (C-5), 52.1 (C-9), 51.5 (C-18), 48.6 (C-19), 46.5 (C-1), 45.7 (-СН 2 -СО-), 43.7 (C-14), 42.2 (C-8), 41.5 (C-4), 40. [1-(3'-Deoxythymidine)-1H-1,2,3-triazole-4-yl]-{[N-2α-methyl-3β-O-(3',3'-dimethylsuccinyl)-lup-20,29-en-28 
N-[3β-Hydroxy-2α-propargyl-lup-20(29)-en-28-oyl]-N'-(tert-butoxycarbonyl)-2-ethylamine (8b

N-[3β-О-(3',3'-Dimethylsuccinyl)-2α-propargyl-lup-20(29)-en-28-oyl]-N'-(tert-butoxycarbonyl)-8-octylamine (17
{[N-(3β-О-(3',3'-Dimethylsuccinyl)-2α-propargyl-lup-20(29)-en-28-oyl)-2-aminoethyl]-carbamoyl}methane
ribose), 5.44-5.40 (m, 1H, H-3'-ribose), 4.71, 4.60 (both br s, 2H, H-29), 2.52 (d, 1H, J 10.0 Hz, H-3), 4.38-4.36 (m, 1H, H-4'-ribose), 3.92 and 3.80 (1H each, dd, J 10.0, 5.0 Hz, H-5'-ribose), 3.04-2.99 (m, 1H, H-19), 2.)
